# A Safety Tolerance and Experimental Hyperalgesia Study of Oral NGX426 in Healthy Male Voluneteers

> **NCT00832546** · PHASE1 · COMPLETED · sponsor: **TorreyPines Therapeutics** · enrollment: 18 (actual)

## Conditions studied

- Healthy
- Hyperalgesia

## Interventions

- **DRUG:** Placebo
- **DRUG:** Oral NGX426 (Powder in solution)

## Key facts

- **NCT ID:** NCT00832546
- **Lead sponsor:** TorreyPines Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2009-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00832546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00832546, "A Safety Tolerance and Experimental Hyperalgesia Study of Oral NGX426 in Healthy Male Voluneteers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00832546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*